Stock ALB ALBEMARLE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Albemarle Corporation

Equities

ALB

US0126531013

Specialty Chemicals

Real-time Estimate Cboe BZX
Other stock markets
 02:51:10 2024-06-06 pm EDT 		5-day change 1st Jan Change
117.7 USD -0.76% Intraday chart for Albemarle Corporation -5.22% -18.80%
07:34pm Chile's Codelco targeting 2030 production for Maricunga lithium site -document RE
Jun. 03 Tianqi weighs bid to protect interests in Chile's SQM-Codelco lithium deal RE

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,745 15,705 27,346 25,406 16,955 13,945 - -
Enterprise Value (EV) 1 10,182 18,530 29,301 27,124 20,232 18,131 18,118 19,039
P/E ratio 14.5 x 41.9 x 221 x 9.49 x 10.8 x 42 x 9.46 x 9.83 x
Yield 2.01% 1.04% 0.67% 0.73% - 1.34% 1.38% 1.43%
Capitalization / Revenue 2.16 x 5.02 x 8.22 x 3.47 x 1.76 x 2.37 x 1.92 x 1.66 x
EV / Revenue 2.84 x 5.92 x 8.8 x 3.71 x 2.1 x 3.08 x 2.49 x 2.26 x
EV / EBITDA 9.82 x 22.6 x 33.6 x 7.8 x 6 x 13.8 x 9.59 x 8.44 x
EV / FCF -76.9 x -359 x -48.1 x 42 x -24.6 x -30.6 x -130 x 47.4 x
FCF Yield -1.3% -0.28% -2.08% 2.38% -4.07% -3.27% -0.77% 2.11%
Price to Book 1.97 x 3.69 x 4.86 x 3.2 x 1.8 x 1.32 x 1.29 x 1.23 x
Nbr of stocks (in thousands) 106,033 106,457 116,976 117,153 117,353 117,527 - -
Reference price 2 73.04 147.5 233.8 216.9 144.5 118.6 118.6 118.6
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,589 3,129 3,328 7,320 9,617 5,895 7,277 8,423
EBITDA 1 1,037 818.7 871 3,476 3,370 1,310 1,889 2,255
EBIT 1 823.3 586.8 617 3,175 2,940 742.4 1,423 1,648
Operating Margin 22.94% 18.75% 18.54% 43.37% 30.57% 12.59% 19.56% 19.57%
Earnings before Tax (EBT) 1 563 373.5 133.6 2,433 246.7 -437.9 1,283 1,931
Net income 1 533.2 375.8 123.7 2,690 1,573 355.2 1,492 2,909
Net margin 14.86% 12.01% 3.72% 36.75% 16.36% 6.02% 20.49% 34.54%
EPS 2 5.020 3.520 1.060 22.84 13.36 2.824 12.54 12.07
Free Cash Flow 1 -132.4 -51.56 -609.4 646.2 -824 -592.2 -138.9 401.7
FCF margin -3.69% -1.65% -18.31% 8.83% -8.57% -10.05% -1.91% 4.77%
FCF Conversion (EBITDA) - - - 18.59% - - - 17.81%
FCF Conversion (Net income) - - - 24.02% - - - 13.81%
Dividend per Share 2 1.470 1.540 1.560 1.580 - 1.588 1.642 1.693
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 894.2 1,128 1,480 2,092 2,621 2,580 2,370 2,311 2,356 1,361 1,378 1,521 1,686 1,546 1,634
EBITDA 1 228.7 431.9 610.2 1,190 1,244 1,596 1,032 453.3 289.1 291.2 291.5 332 388.7 406.6 447.2
EBIT 1 160.5 365.4 539.2 1,112 1,158 1,508 939.2 347.8 145 167.5 177 231.2 265.4 204.6 239.2
Operating Margin 17.95% 32.4% 36.44% 53.17% 44.19% 58.46% 39.62% 15.05% 6.15% 12.31% 12.85% 15.2% 15.74% 13.23% 14.63%
Earnings before Tax (EBT) 1 -8.062 299.6 401.5 869.3 863.1 1,157 168.4 -158.2 -921 -167.6 -48.1 -80.1 -26.05 - -
Net income 1 -3.824 253.4 406.8 897.2 1,132 1,239 650 302.5 -617.7 -9.136 86.3 94.16 126.8 160 186
Net margin -0.43% 22.47% 27.49% 42.89% 43.21% 48% 27.43% 13.09% -26.22% -0.67% 6.26% 6.19% 7.52% 10.35% 11.38%
EPS 2 -0.0300 2.150 3.460 7.610 9.600 10.51 5.520 2.570 -5.260 -0.0800 0.6250 0.6750 0.9450 1.130 1.310
Dividend per Share 2 0.3900 0.3950 0.3950 0.3950 0.3950 0.4000 0.4000 0.4000 - - 0.3867 0.3867 0.3867 0.3900 0.4000
Announcement Date 2/16/22 5/4/22 8/3/22 11/2/22 2/15/23 5/3/23 8/2/23 11/1/23 2/14/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,437 2,825 1,955 1,718 3,277 4,186 4,173 5,095
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.351 x 3.451 x 2.245 x 0.4943 x 0.9723 x 3.196 x 2.209 x 2.259 x
Free Cash Flow 1 -132 -51.6 -609 646 -824 -592 -139 402
ROE (net income / shareholders' equity) 17.1% 9.16% 8.31% 19% 30.1% 3.45% 7.92% 6.88%
ROA (Net income/ Total Assets) 7.37% 3.7% 4.39% 19.6% 15.5% 2.38% 5.98% 8.85%
Assets 1 7,237 10,156 2,817 13,745 10,128 14,943 24,958 32,881
Book Value Per Share 2 37.10 39.90 48.10 67.80 80.20 89.70 92.10 96.20
Cash Flow per Share 2 6.770 7.480 2.970 16.20 11.30 13.00 11.10 17.50
Capex 1 852 850 954 1,262 2,149 1,707 1,612 1,753
Capex / Sales 23.73% 27.18% 28.66% 17.24% 22.35% 28.96% 22.16% 20.81%
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Albemarle Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
118.6 USD
Average target price
153.4 USD
Spread / Average Target
+29.32%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
ALBEMARLE CORPORATION Stock Albemarle Corporation
-18.80% 13.94B
ECOLAB INC. Stock Ecolab Inc.
+20.71% 68.31B
SIKA AG Stock Sika AG
-0.07% 48.94B
GIVAUDAN SA Stock Givaudan SA
+24.11% 44.65B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+29.59% 27.81B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.64% 19.14B
SYMRISE AG Stock Symrise AG
+10.10% 16.76B
CELANESE CORPORATION Stock Celanese Corporation
-5.42% 16.05B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-23.26% 15.55B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A. Stock Sociedad Química y Minera de Chile S.A.
-22.20% 13.38B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. ALB Stock
  4. Financials Albemarle Corporation